Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers

Author:

Monogue Marguerite L.1,Stainton Sean M.1,Baummer-Carr Arlinda1,Shepard Ashley K.2,Nugent James F.2,Kuti Joseph L.1,Nicolau David P.13

Affiliation:

1. Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA

2. Hartford Healthcare Medical Group, Podiatric Surgery, Hartford, Connecticut, USA

3. Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut, USA

Abstract

ABSTRACT Ceftolozane-tazobactam displays potent activity against Gram-negative bacteria that can cause diabetic foot infections (DFI), making it an attractive treatment option when few alternatives exist. The pharmacokinetics and tissue penetration of ceftolozane-tazobactam at 1.5 g every 8 h (q8h) in patients ( n = 10) with DFI were compared with those in healthy volunteers ( n = 6) using in vivo microdialysis. In the patient participants, the median values of the pharmacokinetic parameters for ceftolozane in total plasma were as follows: maximum concentration ( C max ), 55.2 μg/ml (range, 40.9 to 169.3 μg/ml); half-life ( t 1/2 ), 3.5 h (range, 2.3 to 4.7 h); and area under the concentration-time curve (AUC) from time zero to 8 h (AUC 0–8 ), 191.6 μg · h/ml (range, 147.1 to 286.6 μg · h/ml). The median AUC for tissue (AUC tissue ; where AUC tissue was the AUC 0–8 for tissue for ceftolozane)/AUC for plasma for each antibiotic corrected by the fraction of free drug ( f AUC plasma ) was 0.75 (range, 0.35 to 1.00), resulting in a mean free time above 4 μg/ml (the Pseudomonas aeruginosa susceptibility breakpoint) in tissue of 99.8% (range, 87.5 to 100%). In the patient participants, the median values of the pharmacokinetic parameters for tazobactam in total plasma were as follows: C max , 14.2 μg/ml (range, 7.6 to 64.2 μg/ml); t 1/2 , 2.0 h (range, 0.7 to 2.4 h); and AUC 0–8 , 27.1 μg · h/ml (range, 15.0 to 70.0 μg · h/ml). The AUC tissue (where AUC tissue was the AUC from time zero to the time of the last measureable concentration in tissue for tazobactam)/ f AUC plasma for tazobactam was 1.18 (range, 0.54 to 1.44). In the healthy volunteers, the median values of the pharmacokinetic parameters for ceftolozane in total plasma were as follows: C max , 91.5 μg/ml (range, 65.7 to 110.7 μg/ml); t 1/2 , 1.9 h (range, 1.6 to 2.1 h); and AUC 0–8 , 191.3 μg · h/ml (range, 118.1 to 274.3 μg · h/ml). The median AUC tissue / f AUC plasma was 0.87 (range, 0.54 to 2.20), resulting in a mean free time above 4 μg/ml in tissue of 93.8% (range, 87.5 to 100%). In the healthy volunteers, the median values of the pharmacokinetic parameters for tazobactam in total plasma were as follows: C max , 17.5 μg/ml (range, 15.4 to 27.3 μg/ml); t 1/2 , 0.7 h (range, 0.6 to 0.8 h); and AUC 0–8 , 22.2 μg · h/ml (range, 19.2 to 36.4 μg · h/ml). The AUC tissue / f AUC plasma for tazobactam was 0.85 (range, 0.63 to 2.10). Both ceftolozane and tazobactam penetrated into subcutaneous tissue with exposures similar to those of free drug in plasma in both patients with DFI and healthy volunteers. These data suggest that ceftolozane-tazobactam at 1.5 g q8h can achieve the optimal exposure with activity against susceptible Gram-negative pathogens in the tissue of patients with DFI. (This study has been registered at ClinicalTrials.gov under identifier NCT02620774.)

Funder

Merck

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3